Oncotarget

Vol 10, No 47

August 6, 2019

View Archive »

Order a Reprint

About The Cover

The cover for issue 47 of Oncotarget features Figure 1, "Single agent and combinatorial drug sensitivity of HMLE-shEcad (red) and HMLE-shGFP (blue)," by Colavito, et al.

Table of Contents

Editorial

Adding genetic scores to risk models in colorectal cancer

Adding genetic scores to risk models in colorectal cancer

https://doi.org/10.18632/oncotarget.27110

Carla J. Gargallo-Puyuelo, Ángel Lanas,  and María Asunción García-Gonzalez
4803-4804
PDF  |  How to cite  |  Order a Reprint

MRI-based prediction of molecular subgrouping in medulloblastoma: images speak louder than words

MRI-based prediction of molecular subgrouping in medulloblastoma: images speak louder than words

https://doi.org/10.18632/oncotarget.27097

Archya Dasgupta,  and Tejpal Gupta
4805-4807
PDF  |  How to cite  |  Order a Reprint

Research Papers

Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in in vitro experiments

Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in in vitro experiments

https://doi.org/10.18632/oncotarget.27093

Maria Zamkova, Anastasiya Kalinina, Yuliya Silaeva, Nadezhda Persiyantseva, Alexandra Bruter, Alexey Deikin, Ludmila Khromykh,  and Dmitry Kazansky
4808-4821
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer

https://doi.org/10.18632/oncotarget.27104

Sierra A. Colavito, James T. Platt, Matthew A. Held, Zongzhi Liu, Ryan Sokup,  and David F. Stern
4822-4839
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth

Role of the P2X7 receptor in in vitro and in vivo glioma tumor growth

https://doi.org/10.18632/oncotarget.27106

Letícia Scussel Bergamin, Marina Capece, Erica Salaro, Alba Clara Sarti, Simonetta Falzoni, Mery Stéfani Leivas Pereira, Marco Antônio De Bastiani, Juliete Nathali Scholl, Ana Maria O. Battastini,  and Francesco Di Virgilio
4840-4856
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort

Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort

https://doi.org/10.18632/oncotarget.27108

Tomi Akinyemiju, Justin X. Moore, Maria Pisu, Michael Goodman, Virginia J. Howard, Monika Safford, Susan C. Gilchrist, Mary Cushman, LeAnn Long,  and Suzanne E. Judd
4857-4867
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

AUF1 positively controls angiogenesis through mRNA stabilization-dependent up-regulation of HIF-1α and VEGF-A in human osteosarcoma

AUF1 positively controls angiogenesis through mRNA stabilization-dependent up-regulation of HIF-1α and VEGF-A in human osteosarcoma

https://doi.org/10.18632/oncotarget.27115

Huda H. Al-Khalaf,  and Abdelilah Aboussekhra
4868-4879
Abstract  |  PDF  |  HTML  |  How to cite  |  Order a Reprint

MicroRNA-34a/IL-6R pathway as a potential therapeutic target for ovarian high-grade serous carcinoma

MicroRNA-34a/IL-6R pathway as a potential therapeutic target for ovarian high-grade serous carcinoma

https://doi.org/10.18632/oncotarget.27117

Ryo Yokomizo, Nozomu Yanaihara, Noriko Yamaguchi, Misato Saito, Ayako Kawabata, Kazuaki Takahashi, Masataka Takenaka, Kyosuke Yamada, Jason Solomon Shapiro,  and Aikou Okamoto
4880-4893
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

Expression and function of Kv1.3 channel in malignant T cells in Sézary syndrome

https://doi.org/10.18632/oncotarget.27122

Tengpeng Hu, Terkild Brink Buus, Thorbjørn Krejsgaard, Anneline Nansen, Betina Kerstin Lundholt, Pieter Spee, Simon Fredholm, David Leander Petersen, Edda Blümel, Maria Gluud, Madalena N. Monteiro, Andreas Willerslev-Olsen, Mads Hald Andersen, Per thor Straten, Özcan Met, Veronica Stolearenco, Hanne Fogh, Robert Gniadecki, Claudia Nastasi, Thomas Litman, Anders Woetmann, Lise Mette Rahbek Gjerdrum,  and Niels Ødum
4894-4906
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer

The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer

https://doi.org/10.18632/oncotarget.27127

Masafumi Iida, Misato Nakamura, Emi Tokuda, Daichi Toyosawa, Toshifumi Niwa, Noriaki Ohuchi, Takanori Ishida,  and Shin-ichi Hayashi
4907-4918
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  How to cite  |  Order a Reprint

Corrections

Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget

Correction: Targeting a ribonucleoprotein complex containing the caprin-1 protein and the c-Myc mRNA suppresses tumor growth in mice: an identification of a novel oncotarget

https://doi.org/10.18632/oncotarget.27074

Ya-Qi Qiu, Cheng-Wei Yang, Yue-Zhi Lee, Ruey-Bing Yang, Chih-Hao Lee, Hsing-Yu Hsu, Chien-Chung Chang,  and Shiow-Ju Lee
4919-4919
Correction  |  PDF  |  How to cite

Correction: Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer

Correction: Exploiting the transcriptional specificity of the alpha-methylacyl-CoA racemase AMACR promoter for the molecular imaging of prostate cancer

https://doi.org/10.18632/oncotarget.27143

Mariya Shapovalova, Julia Davydova, Christine Henzler, Mark Daniel, Scott M. Dehm, Christopher A. Warlick,  and Aaron M. LeBeau
4920-4920
Correction  |  PDF  |  How to cite


Copyright © 2019 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC